3 results
Approved WMORecruiting
Primary- Continuation of treatment- SafetySecondairy- Documentation of tolerability
Approved WMORecruiting
To study the effects of continuous use of ethinylestradiol/levonorgestrel (30/150 µg/day) compared to vitamin E (400 IU/day) in the treatment of menstrually-related migraine and migraine during perimenopause.
Approved WMOCompleted
Primary objective To investigate the safety and tolerability of CCS1477 as monotherapy and in combination.